{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:20:00Z","timestamp":1793272800534,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.dsx.2026.103472","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:33:29Z","timestamp":1786664009000},"page":"103472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Feto-maternal safety of statins in pregnancy: An updated systematic review and meta-analysis"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4915-8805","authenticated-orcid":false,"given":"Deep","family":"Dutta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sweekruti","family":"Jena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5681-6522","authenticated-orcid":false,"given":"A.B.M.","family":"Kamrul-Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saptarshi","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.dsx.2026.103472_bib1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jamacardio.2024.3911","article-title":"Alternative LDL cholesterol\u2013lowering strategy vs high-intensity statins in atherosclerotic cardiovascular disease: a systematic review and individual patient data meta-analysis","volume":"10","author":"Lee","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.dsx.2026.103472_bib2","article-title":"Cardiovascular and obstetric safety of pregnancy in women with premature coronary artery disease","volume":"14","author":"Mikou","year":"2025","journal-title":"Eur J Prev Cardiol"},{"issue":"9","key":"10.1016\/j.dsx.2026.103472_bib3","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1111\/bcp.15423","article-title":"Pregnancy outcomes following maternal exposure to statins: a systematic review and meta\u2010analysis","volume":"88","author":"Karadas","year":"2022","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.dsx.2026.103472_bib4","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1345\/aph.1R202","article-title":"Teratogenic risk of statins in pregnancy","volume":"46","author":"Godfrey","year":"2012","journal-title":"Ann Pharmacother"},{"issue":"10","key":"10.1016\/j.dsx.2026.103472_bib5","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jacc.2019.03.009","article-title":"ACC\/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.dsx.2026.103472_bib6","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1186\/s12884-025-07967-5","article-title":"The role of statins during pregnancy on maternal risk of preeclampsia: a systematic review and meta-analysis","volume":"25","author":"Khalili","year":"2025","journal-title":"BMC Pregnancy Childbirth"},{"issue":"11","key":"10.1016\/j.dsx.2026.103472_bib7","article-title":"Statins No longer contraindicated in pregnancy","volume":"121","author":"Aschenbrenner","year":"2021","journal-title":"AJN Am J Nurs"},{"issue":"1","key":"10.1016\/j.dsx.2026.103472_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.36660\/abc.20220413","article-title":"Estatinas na Gesta\u00e7\u00e3o \u2013 novas recomenda\u00e7\u00f5es do food and drug administration","volume":"119","author":"Bittencourt","year":"2022","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.dsx.2026.103472_bib9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.preghy.2020.11.014","article-title":"Effects of statins on preeclampsia: a systematic review","volume":"23","author":"Vahedian-Azimi","year":"2021","journal-title":"Pregnancy Hypertens"},{"issue":"6","key":"10.1016\/j.dsx.2026.103472_bib10","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S1701-2163(15)30565-X","article-title":"The fetal safety of statins: a systematic review and meta-analysis","volume":"36","author":"Zarek","year":"2014","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.dsx.2026.103472_bib11","doi-asserted-by":"crossref","DOI":"10.1097\/CRD.0000000000000906","article-title":"The use of statins during pregnancy in patients diagnosed with preeclampsia: a systematic review","author":"Gera","year":"2025","journal-title":"Cardiol Rev"},{"issue":"5","key":"10.1016\/j.dsx.2026.103472_bib12","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jacl.2016.07.002","article-title":"The risks of statin use in pregnancy: a systematic review","volume":"10","author":"Karalis","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.dsx.2026.103472_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2021.09.010","article-title":"A systematic review and meta-analysis on the effects of statins on pregnancy outcomes","volume":"336","author":"Vahedian-Azimi","year":"2021","journal-title":"Atherosclerosis"},{"issue":"13","key":"10.1016\/j.dsx.2026.103472_bib14","article-title":"The effect of statins exposure during pregnancy on congenital anomalies and spontaneous abortions: a systematic review and meta-analysis","volume":"29","author":"Hirsch","year":"2022","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.dsx.2026.103472_bib15","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s00431-025-06119-3","article-title":"Pregnancy and neonatal outcomes after fetal exposure to statins among women with dyslipidemia: a nationwide cohort","volume":"184","author":"Kay","year":"2025","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.dsx.2026.103472_bib16","article-title":"Statin use in pregnancy and risk of congenital malformations: a Norwegian nationwide study","volume":"21","author":"Christensen","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.dsx.2026.103472_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.120442","article-title":"Risk of adverse pregnancy outcomes and impact of statin use in pregnant women with familial hypercholesterolemia","volume":"408","author":"Svendsen","year":"2025","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.dsx.2026.103472_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.atherosclerosis.2022.11.022","article-title":"Use of statins and other lipid-modifying agents across pregnancy: a nationwide drug utilization study in Norway in 2005\u20132018","volume":"368","author":"Christensen","year":"2023","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.dsx.2026.103472_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.41321","article-title":"Perinatal outcomes after Statin exposure during pregnancy","volume":"4","author":"Chang","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.dsx.2026.103472_bib20","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"n71","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.dsx.2026.103472_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/bdr2.2314","article-title":"Updated EUROCAT guidelines for classification of cases with congenital anomalies","volume":"116","author":"Bergman","year":"2024","journal-title":"Birth Defects Res"},{"issue":"4","key":"10.1016\/j.dsx.2026.103472_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"issue":"7414","key":"10.1016\/j.dsx.2026.103472_bib23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.dsx.2026.103472_bib24","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/CIRCULATIONAHA.121.053963","article-title":"Pravastatin versus placebo in pregnancies at high risk of term Preeclampsia","volume":"144","author":"D\u00f6bert","year":"2021","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.dsx.2026.103472_bib25","doi-asserted-by":"crossref","first-page":"666.e1","DOI":"10.1016\/j.ajog.2021.05.018","article-title":"A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia","volume":"225","author":"Costantine","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.dsx.2026.103472_bib26","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2125.2007.02905.x","article-title":"Risk of congenital anomalies in pregnant users of statin drugs","volume":"64","author":"Ofori","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.dsx.2026.103472_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijcard.2018.07.002","article-title":"Statin exposure during first trimester of pregnancy is associated with fetal ventricular septal defect","volume":"269","author":"Lee","year":"2018","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.dsx.2026.103472_bib28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/1471-0528.12066","article-title":"Pregnancy outcome following maternal exposure to statins: a multicentre prospective study","volume":"120","author":"Winterfeld","year":"2013","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.dsx.2026.103472_bib29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.reprotox.2008.06.009","article-title":"Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes","volume":"26","author":"Taguchi","year":"2008","journal-title":"Reprod Toxicol"},{"issue":"7","key":"10.1016\/j.dsx.2026.103472_bib30","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/pds.4176","article-title":"Statins during pregnancy: a cohort study using the General Practice research database to investigate pregnancy loss","volume":"26","author":"McGrogan","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.dsx.2026.103472_bib31","first-page":"2081","article-title":"Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: the potential role of statins","author":"Chaman","year":"2024","journal-title":"J Popul Ther Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.dsx.2026.103472_bib32","doi-asserted-by":"crossref","first-page":"710","DOI":"10.21608\/ejhm.2018.17508","article-title":"Effect of pravastatin on the incidence of preeclampsia","volume":"73","author":"Hassanain","year":"2018","journal-title":"Egypt J Hosp Med"},{"issue":"9","key":"10.1016\/j.dsx.2026.103472_bib33","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1055\/a-1798-1925","article-title":"INOVASIA study: a multicenter randomized clinical trial of pravastatin to prevent preeclampsia in high-risk patients","volume":"41","author":"Akbar","year":"2024","journal-title":"Am J Perinatol"},{"issue":"6","key":"10.1016\/j.dsx.2026.103472_bib34","doi-asserted-by":"crossref","first-page":"720.e1","DOI":"10.1016\/j.ajog.2015.12.038","article-title":"Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial","volume":"214","author":"Costantine","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.dsx.2026.103472_bib35","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/1471-0528.16013","article-title":"Pravastatin for early\u2010onset pre\u2010eclampsia: a randomized, blinded, placebo\u2010controlled trial","volume":"127","author":"Ahmed","year":"2020","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.dsx.2026.103472_bib36","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.enfcli.2019.07.147","article-title":"The effect of pravastatin on endothelin-1 levels and pregnancy outcomes in women who have a high risk for preeclampsia: a randomized control trial","volume":"30","author":"Riu","year":"2020","journal-title":"Enferm Cl\u00ednica"},{"issue":"mar17 10","key":"10.1016\/j.dsx.2026.103472_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h1035","article-title":"Statins and congenital malformations: cohort study","volume":"350","author":"Bateman","year":"2015","journal-title":"BMJ"},{"issue":"14","key":"10.1016\/j.dsx.2026.103472_bib38","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1055\/s-0040-1713651","article-title":"Evaluating the effect of pravastatin in early-onset fetal growth restriction: a non-randomized and historically controlled pilot study","volume":"38","author":"Mendoza","year":"2021","journal-title":"Am J Perinatol"},{"issue":"S 01","key":"10.1016\/j.dsx.2026.103472_bib39","doi-asserted-by":"crossref","DOI":"10.1055\/s-0028-1089105","article-title":"Einsatz von Statinen bei Hypercholesterin\u00e4mie in der Fr\u00fchschwangerschaft","volume":"68","author":"Paulus","year":"2008","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.dsx.2026.103472_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2020.106824","article-title":"Pravastatin plus L-arginine prevents adverse pregnancy outcomes in women with uteroplacental vascular dysfunction","volume":"137","author":"Jurisic","year":"2021","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.dsx.2026.103472_bib41","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.atherosclerosis.2018.05.038","article-title":"Statins and other lipid-lowering therapy and pregnancy outcomes in homozygous familial hypercholesterolaemia: a retrospective review of 39 pregnancies","volume":"277","author":"Botha","year":"2018","journal-title":"Atherosclerosis"},{"issue":"20","key":"10.1016\/j.dsx.2026.103472_bib42","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1002\/ajmg.a.32493","article-title":"Maternal exposure to statins and risk for birth defects: a case\u2010series approach","volume":"146A","author":"Petersen","year":"2008","journal-title":"Am J Med Genet"},{"issue":"11","key":"10.1016\/j.dsx.2026.103472_bib43","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/bdra.20181","article-title":"Pregnancy outcomes after maternal exposure to simvastatin and lovastatin","volume":"73","author":"Pollack","year":"2005","journal-title":"Birt Defects Res A Clin Mol Teratol"},{"issue":"11","key":"10.1016\/j.dsx.2026.103472_bib44","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/pds.1995","article-title":"Linking a pharmaceutical claims database with a birth defects registry to investigate birth defect rates of suspected teratogens","volume":"19","author":"Colvin","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"10.1016\/j.dsx.2026.103472_bib45","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0890-6238(96)00130-X","article-title":"Postmarketing surveillance of lovastatin and simvastatin exposure during pregnancy","volume":"10","author":"Manson","year":"1996","journal-title":"Reprod Toxicol"},{"issue":"2","key":"10.1016\/j.dsx.2026.103472_bib46","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/14740338.2024.2442519","article-title":"Congenital anomalies associated with the use of cardiovascular drugs during pregnancy: a large-scale data analysis from the FAERS database","volume":"24","author":"Zheng","year":"2025","journal-title":"Expert Opin Drug Saf"},{"issue":"8","key":"10.1016\/j.dsx.2026.103472_bib47","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1172\/JCI86957","article-title":"Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy","volume":"126","author":"Lefkou","year":"2016","journal-title":"J Clin Investig"},{"issue":"8","key":"10.1016\/j.dsx.2026.103472_bib48","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1080\/14767058.2017.1402880","article-title":"The prevalence of congenital malformations is still higher in pregnant women with pregestational diabetes despite near-normal HbA1c: a literature review","volume":"32","author":"Eriksen","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"10.1016\/j.dsx.2026.103472_bib49","doi-asserted-by":"crossref","first-page":"337.e1","DOI":"10.1016\/j.ajog.2014.09.031","article-title":"Chronic hypertension in pregnancy and the risk of congenital malformations: a cohort study","volume":"212","author":"Bateman","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.dsx.2026.103472_bib50","doi-asserted-by":"crossref","first-page":"e664","DOI":"10.1016\/j.jacl.2024.05.005","article-title":"Dyslipidemia management in women of reproductive potential: an expert clinical consensus from the National lipid association","volume":"18","author":"Agarwala","year":"2024","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.dsx.2026.103472_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1076372","article-title":"Pravastatin in preeclampsia: a meta-analysis and systematic review","volume":"9","author":"M\u00e9sz\u00e1ros","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.dsx.2026.103472_bib52","article-title":"Clinical repercussions of statin use during pregnancy: a review of the literature","volume":"47","author":"Lins","year":"2025","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"3","key":"10.1016\/j.dsx.2026.103472_bib53","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeae032","article-title":"Dyslipidaemia management in pregnant patients: a 2024 update","volume":"4","author":"Lewek","year":"2024","journal-title":"Eur Heart J Open"},{"key":"10.1016\/j.dsx.2026.103472_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2026.120679","article-title":"Challenges in the care of women with familial hypercholesterolaemia during the reproductive period - current evidence and practical guidance","volume":"415","author":"Holven","year":"2026","journal-title":"Atherosclerosis"}],"container-title":["Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402126000998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402126000998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:09:34Z","timestamp":1787011774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402126000998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1871402126000998"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2026.103472","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feto-maternal safety of statins in pregnancy: An updated systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2026.103472","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC). Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103472"}}